GB202113610D0 - Novel method - Google Patents
Novel methodInfo
- Publication number
- GB202113610D0 GB202113610D0 GBGB2113610.6A GB202113610A GB202113610D0 GB 202113610 D0 GB202113610 D0 GB 202113610D0 GB 202113610 A GB202113610 A GB 202113610A GB 202113610 D0 GB202113610 D0 GB 202113610D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel method
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2113610.6A GB202113610D0 (en) | 2021-09-23 | 2021-09-23 | Novel method |
PCT/GB2022/052410 WO2023047123A1 (fr) | 2021-09-23 | 2022-09-23 | Procédé de détermination de l'adéquation d'un inhibiteur exo1 pour le traitement du cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2113610.6A GB202113610D0 (en) | 2021-09-23 | 2021-09-23 | Novel method |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202113610D0 true GB202113610D0 (en) | 2021-11-10 |
Family
ID=78399808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2113610.6A Ceased GB202113610D0 (en) | 2021-09-23 | 2021-09-23 | Novel method |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB202113610D0 (fr) |
WO (1) | WO2023047123A1 (fr) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090062196A1 (en) * | 2006-10-20 | 2009-03-05 | D Andrea Alan | Compositions and methods of treating cancer |
WO2016012630A1 (fr) * | 2014-07-25 | 2016-01-28 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Procédés pour prédire la réponse à des inhibiteurs de la voie de réparation de l'adn dans un lymphome diffus à grandes cellules b |
AU2016325601C1 (en) | 2015-09-25 | 2022-03-31 | Ludwig Institute For Cancer Research Ltd. | 3-hydroxy-quinazoline-2,4-dione derivatives and their use as nuclease modulators |
US11584755B2 (en) * | 2017-09-26 | 2023-02-21 | Ideaya Biosciences, Inc. | Dihydrothieno[3,2-b]pyridine compounds |
-
2021
- 2021-09-23 GB GBGB2113610.6A patent/GB202113610D0/en not_active Ceased
-
2022
- 2022-09-23 WO PCT/GB2022/052410 patent/WO2023047123A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
WO2023047123A1 (fr) | 2023-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB202010104D0 (en) | Method | |
GB202004944D0 (en) | Method | |
GB202007724D0 (en) | Novel method | |
GB202015993D0 (en) | Method | |
GB202007044D0 (en) | Method | |
GB202006815D0 (en) | Method | |
GB202004863D0 (en) | Method | |
GB202014709D0 (en) | Method | |
GB202014432D0 (en) | Method | |
GB202011823D0 (en) | Method | |
GB202010922D0 (en) | Method | |
GB202010046D0 (en) | Method | |
GB202006047D0 (en) | Method | |
GB202004515D0 (en) | Method | |
GB202003580D0 (en) | Method | |
IL307395A (en) | A new method | |
GB202114206D0 (en) | Novel method | |
GB202113610D0 (en) | Novel method | |
GB202103328D0 (en) | Novel method | |
GB202103325D0 (en) | Novel method | |
GB202103327D0 (en) | Novel method | |
GB202018476D0 (en) | Novel method | |
GB202017725D0 (en) | Method | |
GB202016334D0 (en) | Method | |
GB202015479D0 (en) | Method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |